Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 43 minutes ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately in the Division of Cell Therapy (DCT2), within the Office of Cellular
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 42 minutes ago
for two years, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full time. Citizenship Requirements: This opportunity
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 42 minutes ago
the application of state of the art methods such as single cell RNA-Seq/ATAC seq/spatial transcriptomics on preclinical animal models towards understanding the mechanisms of pathogenesis and defining correlates
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 44 minutes ago
flexible and will depend on a variety of factors. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 29 minutes ago
, conditions, or injury. The project will employ a variety of approaches including large scale cell manufacturing, extracellular vesicle manufacturing and characterization, biomaterials, high content imaging
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 29 minutes ago
diseases, conditions, or injury. The successful candidate will perform laboratory research on projects related to cell and gene therapy. The candidate will use advanced manufacturing tools and strategies
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 34 minutes ago
will help define the mechanisms high-risk clones utilize to cause disease and modulate immune cell function during distinct pulmonary insults. These data will provide insights into the immediate and
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 34 minutes ago
. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 35 minutes ago
will depend on a variety of factors. Appointment Length: The appointment will initially be for 6 months, but may be renewed upon recommendation of FDA and is contingent on the availability of funds
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 28 minutes ago
-on experience in routine molecular biology techniques and cell culture. Ability to act collaboratively and adopt new technologies outside their comfort zone is an essential quality for this appointment. Previous